November 27, 2021
EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

EU regulator authorizes Pfizer’s COVID vaccine for kids 5-11

THE HAGUE, Netherlands — The European Union’s drug regulator on Thursday approved Pfizer’s coronavirus vaccine for use on kids from 5 to 11 years previous, clearing the way in which for photographs to be administered to hundreds of thousands of elementary college pupils amid a brand new wave of infections sweeping throughout the continent.

It’s the first time the European Medicines Company has cleared a COVID-19 vaccine for use in younger kids.

The company stated it “recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11.”

At the least one nation going through spiking infections did not wait for the EMA approval. Authorities within the Austrian capital, Vienna, have already got begun vaccinating the 5 to 11 age group. Europe is presently on the epicenter of the pandemic and the World Well being Group has warned the continent might see deaths prime 2 million by the spring except pressing measures are taken.

America signed off on Pfizer’s kids-sized photographs earlier this month, adopted by different international locations together with Canada.

Pfizer examined a dose that may be a third of the quantity given to adults for elementary school-age kids. Even with the smaller shot, kids who’re 5 to 11 years previous developed coronavirus-fighting antibody ranges simply as robust as youngsters and younger adults getting the regular-strength photographs, Dr. Invoice Gruber, a Pfizer senior vp, informed The Related Press in September.

However the research carried out on Pfizer’s vaccine in kids haven’t been sufficiently big to detect any uncommon uncomfortable side effects from the second dose, just like the chest and coronary heart irritation that has been seen in principally male older teenagers and younger adults.

American officers famous that COVID-19 has prompted extra deaths in kids within the 5 to 11 age group than another ailments, reminiscent of chickenpox, did earlier than kids have been routinely vaccinated.

Earlier this month, the EMA stated it started evaluating the usage of Moderna Inc.‘s COVID-19 vaccine for kids ages 6 to 11; it estimated {that a} choice can be made inside two months.

Though kids principally solely get delicate signs of COVID-19, some public well being consultants imagine immunizing them ought to be a precedence to cut back the virus’ continued unfold, which might theoretically result in the emergence of a harmful new variant.

Researchers disagree on how a lot kids have influenced the course of the pandemic. Early analysis prompt they didn’t contribute a lot to viral unfold. However some consultants say kids performed a major position this 12 months spreading contagious variants reminiscent of alpha and delta.

In a press release this week, WHO stated that as a result of kids and teenagers are likely to have milder COVID-19 illness than adults, “it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.”

It has appealed to wealthy international locations to cease immunizing kids and requested them to donate their doses instantly to poor international locations who’ve but to present a primary vaccine dose to their well being staff and weak populations.

Nonetheless, WHO acknowledged that there are advantages to vaccinating kids and adolescents that transcend the instant well being advantages.

“Vaccination that decreases COVID transmission in this age group may reduce transmission from children and adolescents to older adults, and may help reduce the need for mitigation measures in schools,” WHO stated.


Maria Cheng reported from London.


Comply with AP’s protection of the coronavirus pandemic at

Source link